These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 22766660

  • 1. Prevalence and significance of decreased bone density in pulmonary arterial hypertension.
    Malik N, McCarthy K, Minai OA.
    South Med J; 2012 Jul; 105(7):344-9. PubMed ID: 22766660
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Impact of pulmonary hemodynamics on 6-min walk test in idiopathic pulmonary fibrosis.
    Minai OA, Santacruz JF, Alster JM, Budev MM, McCarthy K.
    Respir Med; 2012 Nov; 106(11):1613-21. PubMed ID: 22902266
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The clinical characteristics of systemic sclerosis-related pulmonary arterial hypertension].
    Wang H, Tian Z, Liu Y, Li M, Wang Q, Zeng X, Fang Q.
    Zhonghua Nei Ke Za Zhi; 2014 May; 53(5):390-3. PubMed ID: 25146407
    [Abstract] [Full Text] [Related]

  • 6. Patients with scleroderma may have increased risk of osteoporosis. A comparison to rheumatoid arthritis and noninflammatory musculoskeletal conditions.
    Yuen SY, Rochwerg B, Ouimet J, Pope JE.
    J Rheumatol; 2008 Jun; 35(6):1073-8. PubMed ID: 18412305
    [Abstract] [Full Text] [Related]

  • 7. Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension.
    Mathai SC, Girgis RE, Fisher MR, Champion HC, Housten-Harris T, Zaiman A, Hassoun PM.
    Eur Respir J; 2007 Mar; 29(3):469-75. PubMed ID: 17079256
    [Abstract] [Full Text] [Related]

  • 8. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis.
    Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF.
    Chest; 2006 Mar; 129(3):746-52. PubMed ID: 16537877
    [Abstract] [Full Text] [Related]

  • 9. A prospective study of the 6 min walk test as a surrogate marker for haemodynamics in two independent cohorts of treatment-naïve systemic sclerosis-associated pulmonary arterial hypertension.
    Sanges S, Launay D, Rhee RL, Sitbon O, Hachulla É, Mouthon L, Guillevin L, Rottat L, Montani D, De Groote P, Cottin V, Magro P, Prévot G, Bauer F, Bergot E, Chabanne C, Reynaud-Gaubert M, Leroy S, Canuet M, Sanchez O, Gut-Gobert C, Dauphin C, Pison C, Boissin C, Habib G, Clerson P, Conesa F, Cordier JF, Kawut SM, Simonneau G, Humbert M.
    Ann Rheum Dis; 2016 Aug; 75(8):1457-65. PubMed ID: 26324844
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies.
    Le Pavec J, Girgis RE, Lechtzin N, Mathai SC, Launay D, Hummers LK, Zaiman A, Sitbon O, Simonneau G, Humbert M, Hassoun PM.
    Arthritis Rheum; 2011 Aug; 63(8):2456-64. PubMed ID: 21538327
    [Abstract] [Full Text] [Related]

  • 12. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
    Conde FA, Sarna L, Oka RK, Vredevoe DL, Rettig MB, Aronson WJ.
    Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
    [Abstract] [Full Text] [Related]

  • 13. Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil.
    Launay D, Sitbon O, Le Pavec J, Savale L, Tchérakian C, Yaïci A, Achouh L, Parent F, Jais X, Simonneau G, Humbert M.
    Rheumatology (Oxford); 2010 Mar; 49(3):490-500. PubMed ID: 20015974
    [Abstract] [Full Text] [Related]

  • 14. Depressive symptoms in pulmonary arterial hypertension: prevalence and association with functional status.
    McCollister DH, Beutz M, McLaughlin V, Rumsfeld J, Masoudi FA, Tripputi M, Yaeger T, Weintraub P, Badesch DB.
    Psychosomatics; 2010 Mar; 51(4):339-339.e8. PubMed ID: 20587763
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.
    Williams MH, Handler CE, Akram R, Smith CJ, Das C, Smee J, Nair D, Denton CP, Black CM, Coghlan JG.
    Eur Heart J; 2006 Jun; 27(12):1485-94. PubMed ID: 16682379
    [Abstract] [Full Text] [Related]

  • 18. Bone density in heart or lung transplant recipients--a longitudinal study.
    Wang TK, O'Sullivan S, Gamble GD, Ruygrok PN.
    Transplant Proc; 2013 Jun; 45(6):2357-65. PubMed ID: 23747143
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.
    Cazanave C, Dupon M, Lavignolle-Aurillac V, Barthe N, Lawson-Ayayi S, Mehsen N, Mercié P, Morlat P, Thiébaut R, Dabis F, Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
    AIDS; 2008 Jan 30; 22(3):395-402. PubMed ID: 18195566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.